Original language | English |
---|---|
Pages (from-to) | e539-e541 |
Journal | The Lancet Digital Health |
Volume | 3 |
Issue number | 9 |
Early online date | 9 Aug 2021 |
DOIs |
|
Publication status | Published - Sept 2021 |
Keywords
- COVID-19
Access to Document
- Shah_2021_Predicted-COVID-19_CC
Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license.
Final published version, 221 KBLicence: CC BY-NC-ND
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: The Lancet Digital Health, Vol. 3, No. 9, 09.2021, p. e539-e541.
Research output: Contribution to journal › Comment/debate
TY - JOUR
T1 - Predicted COVID-19 positive cases, hospitalisations, and deaths associated with the Delta variant of concern, June-July, 2021
AU - Shah, Syed Ahmar
AU - Moore, Emily
AU - Robertson, Chris
AU - McMenamin, Jim
AU - Katikireddi, Srinivasa Vittal
AU - Simpson, Colin R
AU - Shi, Ting
AU - Agrawal, Uktarsh
AU - McCowan, Colin
AU - Stock, Sarah
AU - Ritchie, Lewis D
AU - Sheikh, Aziz
AU - Public Health Scotland and the EAVE II Collaborators
N1 - Funding: EAVE II is funded by the Medical Research Council (MR/R008345/1) with the support of BREATHE - The Health Data Research Hub for Respiratory Health [MC_PC_19004], which is funded through the UK Research and Innovation Industrial Strategy Challenge Fund and delivered through Health Data Research UK. Additional support has been provided through Public Health Scotland and Scottish Government DG Health and Social Care and the Data and Connectivity National Core Study, led by Health Data Research UK in partnership with the Office for National Statistics and funded by UK Research and Innovation. SVK is funded by a NHS Research Scotland Senior Clinical Fellowship (SCAF/15/02), the Medical Research Council (MC_UU_00022/2), and the Scottish Government Chief Scientist Office (SPHSU17).
PY - 2021/9
Y1 - 2021/9
KW - COVID-19
U2 - 10.1016/S2589-7500(21)00175-8
DO - 10.1016/S2589-7500(21)00175-8
M3 - Comment/debate
SN - 2589-7500
VL - 3
SP - e539-e541
JO - The Lancet Digital Health
JF - The Lancet Digital Health
IS - 9
ER -